Department of Cell and Molecular Biology, Faculty of Biotechnology and Biomolecular Sciences, Universiti Putra Malaysia, Serdang 43400, Malaysia.
Institute of Tropical Forestry and Forest Products, Universiti Putra Malaysia, Serdang 43400, Malaysia.
Cells. 2022 Nov 10;11(22):3556. doi: 10.3390/cells11223556.
Tumour heterogeneity refers to the complexity of cell subpopulations coexisting within the tumour microenvironment (TME), such as proliferating tumour cells, tumour stromal cells and infiltrating immune cells. The bidirectional interactions between cancer and the surrounding microenvironment mark the tumour survival and promotion functions, which allow the cancer cells to become invasive and initiate the metastatic cascade. Importantly, these interactions have been closely associated with metabolic reprogramming, which can modulate the differentiation and functions of immune cells and thus initiate the antitumour response. The purpose of this report is to review the CD36 receptor, a prominent cell receptor in metabolic activity specifically in fatty acid (FA) uptake, for the metabolic symbiosis of cancer-macrophage. In this review, we provide an update on metabolic communication between tumour cells and macrophages, as well as how the immunometabolism indirectly orchestrates the tumour metastasis.
肿瘤异质性是指肿瘤微环境(TME)中细胞亚群的复杂性,例如增殖的肿瘤细胞、肿瘤基质细胞和浸润的免疫细胞。癌症与周围微环境之间的双向相互作用标志着肿瘤的存活和促进功能,使癌细胞变得侵袭性并启动转移级联。重要的是,这些相互作用与代谢重编程密切相关,代谢重编程可以调节免疫细胞的分化和功能,从而启动抗肿瘤反应。本报告的目的是综述 CD36 受体,这是一种在脂肪酸(FA)摄取中代谢活性的重要细胞受体,用于肿瘤-巨噬细胞的代谢共生。在本综述中,我们提供了肿瘤细胞和巨噬细胞之间代谢通讯的最新进展,以及免疫代谢如何间接协调肿瘤转移。